Product image of Linezolid Pharmathen (Linezolid) supplied by GNH India

Linezolid Pharmathen

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Pharmathen (Linezolid)

Linezolid, the active ingredient in Linezolid Pharmathen, is an oxazolidinone presented as an oral tablet for systemic use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in adult patients.

GNH India supplies Linezolid Pharmathen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Pharmathen S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for serious infections caused by Gram‑positive organisms, particularly those resistant to other agents.

  • Methicillin‑resistant Staphylococcus aureus (MRSA): effective against skin, soft‑tissue and bloodstream infections.
  • Vancomycin‑resistant Enterococci (VRE): provides an oral option for resistant enterococcal infections.
  • Community‑acquired bacterial pneumonia: treats pneumonia caused by susceptible Gram‑positive pathogens.
  • Skin and soft‑tissue infections: resolves cellulitis and wound infections due to susceptible organisms.
  • Other Gram‑positive infections: covers a range of infections where the pathogen is susceptible to linezolid.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible Gram‑positive organisms and bactericidal at higher concentrations, leading to suppression of bacterial growth.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: transient gastrointestinal upset.
  • Diarrhea: loose stools, often mild.
  • Headache: occasional tension‑type headache.
  • Metallic taste: transient dysgeusia.
  • Vomiting: occasional emesis.
  • Fatigue: general tiredness.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: sensory changes with prolonged use.
  • Serotonin syndrome: when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuritis: vision changes requiring urgent evaluation.
  • Myelosuppression: bone‑marrow suppression affecting blood cells.

Precautions & Warnings

Before prescribing linezolid, clinicians should assess patient‑specific risk factors and monitor relevant parameters.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: evaluate liver enzymes regularly.
  • Concomitant serotonergic drugs: avoid or monitor closely for serotonin syndrome.
  • Prolonged therapy (>14 days): perform periodic complete blood counts.
  • Pregnancy: safety unknown; avoid unless benefits outweigh risks.
  • Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): may precipitate serotonin syndrome.
  • Rifampicin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential increase in INR, requiring dose adjustment.
  • Phenytoin: may lower linezolid levels, reducing efficacy.
  • Theophylline: possible increase in theophylline concentrations, necessitating monitoring.

Frequently Asked Questions

Linezolid Pharmathen is used for infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococci (VRE), community‑acquired bacterial pneumonia, and skin or soft‑tissue infections where the pathogen is known to be linezolid‑sensitive.

Linezolid binds to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex required for protein synthesis. This inhibition stops bacterial growth, acting bacteriostatically against most Gram‑positive organisms and bactericidally at higher concentrations.

The appropriate dose of Linezolid Pharmathen is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Dosage regimens are individualized and should follow the prescriber’s instructions.

The safety of linezolid in pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Linezolid Pharmathen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Linezolid offers oral bioavailability and activity against resistant Gram‑positive organisms such as MRSA and VRE, where many beta‑lactams are ineffective. Compared with vancomycin, linezolid provides a convenient oral option and does not require therapeutic drug monitoring, though both share risks of hematologic toxicity.

Linezolid Pharmathen should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve potency and ensures product stability throughout its shelf life.

Linezolid Pharmathen is administered orally, typically as a tablet taken with or without food. The exact administration schedule, including frequency and duration, is determined by the prescribing clinician based on the infection being treated.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic agents, and rare events such as lactic acidosis or optic neuritis. Patients on prolonged therapy should be monitored regularly for hematologic and neurologic adverse effects.

Linezolid Pharmathen should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones, in those taking contraindicated serotonergic drugs without appropriate monitoring, and in individuals where the risk–benefit assessment does not favor its use, such as certain pregnant patients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT